Company / Free Cash Flow per Share
PALVELLA THERAPEUTICS, INC. Free Cash Flow per Share History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.19
FY2023
5-year range
-$0.99 / -$0.19
FY2019-FY2023
Trend
+77.9%
vs FY2022
Sector context
#74 of 192
Health Care
What the data says
At $-0.19, PALVELLA THERAPEUTICS, INC.'s free cash flow per share ranks #74 of 192 in the Health Care sector. Free Cash Flow per Share has increased for 4 consecutive years, from $-1.01 in FY2019 to $-0.19 in FY2023.
Based on SEC 10-K filings.
-0.19 in FY2023.
Improved from $-0.87 to $-0.19 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#74 of 192 in Health CareTop 39% of 192This company -$0.19 Sector average $3.32
▼
-105.6% below sector average
Key checks
Key Insights
- PALVELLA THERAPEUTICS, INC.'s free cash flow per share has grown for 4 consecutive years.
- In FY2023, free cash flow per share increased 77.9% year-over-year.
- Ranks #74 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- Strong profit margin: 43.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | -$0.19 | +77.9% |
| FY2022 | -$0.84 | +2.8% |
| FY2021 | -$0.87 | +12.7% |
| FY2020 | -$0.99 | +1.9% |
| FY2019 | -$1.01 | -195.5% |
| FY2018 | $1.06 | +405.9% |
| FY2017 | -$0.35 | +7.5% |
| FY2016 | -$0.38 | +61.0% |
| FY2015 | -$0.96 | -3921.5% |
As of FY2023 · SEC 10-K Annual Filings · Updated Jun 30, 2026